Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
59.00    2.50 (4.42%)
Bid:
58.00
Ask:
60.00
Spread: 2.00 (3.448%)
Market Cap: £55.91m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

Amendment to Share Purchase Agreements

8 Sep 2020 07:01

RNS Number : 2840Y
Panoply Holdings PLC (The)
08 September 2020
 

8 September 2020

 

The Panoply Holdings PLC

("The Panoply", or the "Group")

 

Amendment to Share Purchase Agreements

 

The Panoply (AIM: TPX), the technology-enabled services group focused on digital transformation, announces that the Group has entered into various agreements to amend the terms of a number of its historical share purchase agreements ("SPA"). The details of these amendments are set out below.

 

In line with the Group's strategy, as announced in its recent Annual Report, to consolidate its end-to-end propositions under two full stack brands, The Panoply has agreed to accelerate the end of the earn-out periods in respect of FutureGov and Ameo with a view facilitating full integration into the Group. Ameo is becoming part of FutureGov, supercharging its change delivery and opening new doors within local and central Government for even bigger impact. Ameo supports its clients through full stack change delivery to build the best outcomes for citizens with long term impact. Both Ameo and FutureGov continue to trade strongly in line with expectations.

 

The result of these changes, together with the other amendments detailed below, is to increase the total deferred consideration now known to be payable by The Panoply to £20,835,794. The maximum further shares to be issued as a result of this consideration is 26,395,283, which reduces to 18,719,658 assuming the share price remained constant at 130p, being the closing mid market price on the day prior to this announcement.

 

SPA for the acquisition of the entire issued share capital of FutureGov Ltd ("FG") dated 11 June 2019 (the "FG SPA") 

The parties to the FG SPA have agreed that the FG sellers will receive deferred earn-out consideration equal to a fixed amount of £1,249,290 in respect of the 12 month period ending on 31 March 2021.

 

The FG SPA has been amended so that this amount is to be paid in substitution for amounts that were previously to have been determined by a calculation that was predominantly based on FG's EBITDA performance for the period to 31 March 2021 ("FG Reference Period").  Otherwise the terms of the original FG SPA are not substantially changed, including in respect of the proportion of consideration payable as ordinary shares in the Panoply (96%) ("Panoply Shares") and cash (4%).

 

Further, the number of Panoply Shares to be issued and allotted continues to be calculated by dividing the earn-out price payable by the greater of 83.125 pence and the volume-weighted average mid-market price ("VWAP") over the 30 business days prior to the issue of the relevant Panoply Shares. The timing of the issue and allotment of these Panoply Shares also remains unchanged, being in four tranches following the publication of the accounts of the Panoply for the relevant FG Reference Period.

 

The cash element of the deferred earn-out consideration, being £121,136.40, will be paid by the Panoply within 10 business days of this announcement. 

 

SPA for the acquisition of the entire issued share capital of AMEO Professional Services Limited ("Ameo") dated 10 March 2020 (the "Ameo SPA")

 

The parties to the Ameo SPA have agreed that the Ameo sellers will receive deferred earn-out consideration equal to fixed amounts of: 

 

1. £416,460 in respect of the 17 month period ending on 31 March 2021 and; 

2. £889,710 in respect of the 12 month period ending on 31 March 2022.

 

The Ameo SPA has been amended so that these amounts are to be paid in substitution for amounts that were previously to have been determined by a calculation that was predominantly based on Ameo's EBITDA performance for each of these periods (each an "Ameo Reference Period"). Otherwise the terms of the Ameo SPA are not substantially changed and the number of Panoply Shares to be issued and allotted remains calculated by dividing the earn-out price payable by  the greater of 82 pence and the VWAP over the 30 business days prior to the issue of the relevant Panoply Shares. The timing of the issue and allotment of these Panoply Shares also remains unchanged, being in one tranche following the publication of the Panoply's accounts for the relevant Ameo Reference Period. 

 

SPA for the acquisition of the entire issued share capital of Greenshoot Labs Limited ("GSL") dated 11 February 2019 (the "GSL SPA")

 

The parties to the GSL SPA have agreed that the GSL sellers will receive deferred earn-out consideration equal to a fixed amount of £500,000 in respect of the 12 month period ending on 31 March 2020 (the "First GSL Reference Period"), in substitution for an amount that would have been previously determined by a calculation predominantly based on GSL's EBITDA performance for the First GSL Reference Period. This is to reflect the value of GSL's revenue growth during the period.

 

The calculation for the amount of deferred earn-out consideration in respect of the 12 month period ending on 31 March 2021 (the "Second GSL Reference Period") will remain based on the financial performance of GSL for the Second GSL Reference Period. In addition, the GSL deferred earn-out consideration remains payable by the Panoply by the issue of the relevant number of Panoply Shares (calculated in accordance with the GSL SPA) in one tranche following the publication of the Panoply's accounts for the First and Second GSL Reference Period (as applicable).

 

SPA for the acquisition of the entire issued share capital of Deeson Group Holdings Limited ("DGHL") dated 18 December 2018 (the "DGHL SPA")

 

The maximum total amount of consideration that can be payable under the DGHL SPA has been increased to £4,580,000. This a reflection of the strong financial performance of DGHL.

 

Agreement between Neal Gandhi and Maxine Tolfrey 

 

Neal Gandhi ("NG") has entered into an agreement (the "Agreement") with Maxine Tolfrey ("MT") in relation to MT's rights and obligations pursuant to the share purchase agreement for the acquisition of the entire issued share capital of Questers dated 11 May 2018 (the "Questers SPA"). 

 

Pursuant to the Agreement, MT has agreed that she will transfer to NG any further consideration she may receive pursuant to the Questers SPA. The Agreement has been entered into in compliance with the divorce settlement between NG and MT.

 

Related party transactions

 

The entry into the amendment agreements with the shareholders of FG, Ameo, GSL and DGHL each constitute related party transactions under the AIM Rules for Companies. The Directors of The Panoply (who are all independent in relation to these matters), having consulted with Stifel, consider that the terms of those various amendment agreements are fair and reasonable insofar as the Group's shareholders are concerned.

 

Enquiries:

 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Broker)

Fred Walsh

Alex Price

 

 

Via Alma PR

 

 

+44 (0)207 710 7600

Alma PR

(Financial PR)

Susie Hudson

Josh Royston

Harriet Jackson

panoply@almapr.co.uk

+44(0)203 405 0209

 

 

 

 

About The Panoply

 

The Panoply is a digitally native technology services company, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

 

The Group is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c. 70% of its client base representing the public sector and c. 30% representing the commercial sector.

 

More information is available at www.thepanoply.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAANXEENEEAA
Date   Source Headline
1st Jun 20267:00 amRNSTPXimpact announces £16m contract with the MoJ
11th May 20267:00 amRNSShare Incentive Plan
22nd Apr 20267:00 amRNSFull Year Trading Update and Notice of Results
17th Apr 20264:17 pmRNSNotification of Major Holdings
17th Apr 20267:00 amRNSShare Incentive Plan
20th Mar 20267:00 amRNSShare Incentive Plan
24th Feb 20267:00 amRNSQ3 Trading Update: EBITDA guidance Upgrade
17th Feb 20267:00 amRNSContract Uplift
12th Feb 20267:01 amRNSTPXimpact announces £39m Contract with DEFRA
12th Feb 20267:00 amRNSShare Incentive Plan
11th Feb 20267:00 amRNSTPXimpact announces £22m NHS England contract
9th Jan 20267:00 amRNSShare Incentive Plan
9th Dec 20257:00 amRNSShare Incentive Plan
8th Dec 20255:19 pmRNSHolding(s) in Company
2nd Dec 20252:45 pmRNSExercise of Options, PDMR, & Total Voting Rights
2nd Dec 20257:00 amRNSUnaudited Interim Results
24th Nov 20257:30 amRNSAppointment of Nominated Adviser and Broker
14th Nov 20257:00 amRNSShare Incentive Plan
5th Nov 20257:00 amRNSFirst Half Update & Notice of Results
14th Oct 20255:29 pmRNSShare Incentive Plan
25th Sep 20254:37 pmRNSResult of AGM
9th Sep 20257:00 amRNSShare Incentive Plan
8th Sep 20255:25 pmRNSExercise of Options & PDMR Dealings
8th Sep 20253:27 pmRNSNotification of Major Holdings
5th Sep 202512:37 pmRNSIssuance of Shares & Total Voting Rights
22nd Aug 20257:00 amRNSNotice of AGM
21st Aug 20257:00 amRNSChange of Auditor
12th Aug 20256:05 pmRNSReplacement: FY25 & FY26 Share Awards
11th Aug 20257:00 amRNSPosting of Annual Report
4th Aug 20259:24 amRNSReplacement: FY25 & FY26 Share Awards
4th Aug 20257:00 amRNSFY25 & FY26 Long-Term Incentive Share Award
30th Jul 20257:00 amRNSDebt Facility Renewal Update
14th Jul 20257:00 amRNSAppointment of non-executive director
10th Jul 20257:00 amRNSShare Incentive Plan
24th Jun 20257:00 amRNSUnaudited preliminary results
16th Jun 20259:00 amRNSNotice of Results
12th Jun 20251:17 pmRNSShare Incentive Plan
14th May 20257:00 amRNSTrading Update and Contract Wins
22nd Apr 20257:00 amRNSResignation of Non-Executive Director
11th Apr 20257:00 amRNSShare Incentive Plan
12th Mar 20257:00 amRNSShare Incentive Plan
28th Feb 20253:26 pmRNSChange of Registered Office Address
12th Feb 20257:00 amRNSShare Incentive Plan
6th Feb 20257:00 amRNSQ3 Trading Update and Revised Outlook
3rd Feb 20257:00 amRNSConfirmation of CFO Appointment
15th Jan 20257:00 amRNSShare Incentive Plan
18th Dec 20247:00 amRNSDirectorate Change - Group CFO retirement
11th Dec 20247:00 amRNSShare Incentive Plan
5th Dec 20247:00 amRNSExercise of Options and PDMR Dealings
28th Nov 20247:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.